GLP-2 (60mg vial) $599 GLP-2 60 mg vial from AMIV promotes powerful weight loss and blood sugar regulation through GLP-1 and GIP receptor activation for total metabolic health
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
These disparities are part of the barriers to homeownership that people of color face and that contribute to the persistent racial wealth gap in the United States
Hair Growth Pathway Activation Wnt/-catenin pathway activation for hair follicle development promotes the anagen (growth) phase and enhances follicular proliferation
Amino Acids and Minerals: Tailored solutions for specific health concerns like fatigue, muscle recovery, and immune support
PlexusDx supports precision-wellness conversations with providers by offering genetic context and baseline assessment tools that can inform dosing decisions
